PhRMA to USTR: Add EU to 'Priority Watch List'
This article was originally published in SRA
Executive Summary
The Pharmaceutical Research and Manufacturers of America has called on the US Trade Representative to add the European Union to the US government's "priority watch list," citing its objections to the proposal by the European Medicine Agency to make participant-level clinical trials data used to support the authorization of medicines publicly available1.